Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALISM: Immune Status Markers in Sepsis, Trauma, and Surgery
NCT02638779Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2015
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Open-label trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Percentage of patients meeting the definition of injury-induced-immunosuppression at 8 weeks. Started Dec 2015; status: completed.
Beyond the preview
Go deeper on NCT02638779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638779.